Qualifications

Qualifications for participation in Reading Hospital PGY-1 Pharmacy Residency Program are in accordance with criteria set forth by the American Society of Health-System Pharmacists.

  • Residents shall be graduates of an Accreditation Council for Pharmacy Education (ACPE)-accredited Doctor of Pharmacy degree program.
  • Residents must be licensed or eligible for licensure in Pennsylvania.
  • Residents shall participate in and obey the rules of the Residency Matching Program.

Application Requirements

Residency candidates are required to submit the following items for application to the PGY-1 Pharmacy Residency Program:

  • Copy of curriculum vitae or resume
  • Official transcript from an accredited School/College of Pharmacy
  • Three references from professional colleagues and/or college professors
  • One-page letter of intent/essay expressing professional goals and reason for pursuing a PGY-1 Pharmacy Residency

The Residency Director assesses the completeness of the application materials prior to scheduling candidate interviews.

Residency Advisory Committee members that participate in interviews complete a Residency Candidate Interview Assessment prior to ranking for the ASHP Residency Matching Program. Candidates are ranked based on the assessments by the Residency Advisory Committee and results are submitted to the ASHP Resident Matching Program.

Acknowledgment of Residency Match

Residents matched to Reading Hospital PGY-1 Pharmacy Residency Program will receive an acceptance letter acknowledging the match and delineating the general terms and conditions of the residency. Acknowledgment in writing by the resident will constitute acceptance of the match and agreement to fulfill the duties of the residency position for the upcoming year.

Pharmacy Licensure Verification

Participation in the Reading Hospital PGY-1 Pharmacy Residency Program is contingent on securing and maintaining a license without restriction in the State of Pennsylvania (PA).

  1. Residents will schedule the North American Pharmacist Licensure Examination (NAPLEX) and Multistate Pharmacy Jurisprudence Examination (MPJE) within two business days of receiving authorization to test (ATT). Both exams will be scheduled to be taken no later than the July 31 of the residency year.
    1. The Residency Program Director (RPD) will be notified as soon as possible via email of scheduled exam dates.
    2. If there are unforeseen delays preventing exams from being scheduled by this deadline (i.e., significant delays from the School of Pharmacy/Board of Pharmacy/global pandemic), new specified dates will be determined by the RPD and Resident. If an extension is granted beyond September 30, the resident is expected to complete a minimum of 52 weeks of residency training with at least 2/3 of that time as a licensed pharmacist.
  2. If the Resident does not pass an exam, the Resident is allowed one re-take of the exam provided. They will still be licensed by September 30 of the residency year. Any re-take should be scheduled for the earliest available date to ensure licensure is obtained as close to August 15 of the residency year as is feasible.
    1. The RPD will be notified as soon as possible via email of scheduled exam dates.
  3. If a Resident is not licensed prior to August 15 of the residency year, the following will occur:
    1. Progress in the residency program may be affected, and any activities missed will need to be made up. No extensions of the program will be permitted to support missed activities due to a delay in licensure.
  4. If licensure is not obtained by September 30 of the residency year, the Resident will be dismissed from the Program.
  5. When licensure is obtained electronically, the RPD and staffing longitudinal preceptor will be notified via email by the Resident.
  6. When the physical license is obtained, a copy will be sent via email to the RPD and Inpatient Operations Manager by the Resident.